Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Benefits of flu vaccination for persons with diabetes mellitus: A review.

Goeijenbier M, van Sloten TT, Slobbe L, Mathieu C, van Genderen P, Beyer WEP, Osterhaus ADME.

Vaccine. 2017 Sep 12;35(38):5095-5101. doi: 10.1016/j.vaccine.2017.07.095. Epub 2017 Aug 12. Review.

PMID:
28807608
2.

Rationale for two influenza B lineages in seasonal vaccines: A meta-regression study on immunogenicity and controlled field trials.

Beyer WEP, Palache AM, Boulfich M, Osterhaus ADME.

Vaccine. 2017 Jul 24;35(33):4167-4176. doi: 10.1016/j.vaccine.2017.06.038. Epub 2017 Jun 24.

PMID:
28655451
3.

The confounded effects of age and exposure history in response to influenza vaccination.

Mosterín Höpping A, McElhaney J, Fonville JM, Powers DC, Beyer WEP, Smith DJ.

Vaccine. 2016 Jan 20;34(4):540-546. doi: 10.1016/j.vaccine.2015.11.058. Epub 2015 Dec 5.

4.

Antibody landscapes after influenza virus infection or vaccination.

Fonville JM, Wilks SH, James SL, Fox A, Ventresca M, Aban M, Xue L, Jones TC, Le NMH, Pham QT, Tran ND, Wong Y, Mosterin A, Katzelnick LC, Labonte D, Le TT, van der Net G, Skepner E, Russell CA, Kaplan TD, Rimmelzwaan GF, Masurel N, de Jong JC, Palache A, Beyer WEP, Le QM, Nguyen TH, Wertheim HFL, Hurt AC, Osterhaus ADME, Barr IG, Fouchier RAM, Horby PW, Smith DJ.

Science. 2014 Nov 21;346(6212):996-1000. doi: 10.1126/science.1256427.

5.

Reply: Letter to the editor, Cochrane rearranged.

Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD.

Vaccine. 2015 Jan 1;33(1):13-4. doi: 10.1016/j.vaccine.2014.05.045. Epub 2014 May 20. No abstract available.

PMID:
24852718
6.

Cochrane re-arranged: support for policies to vaccinate elderly people against influenza.

Beyer WE, McElhaney J, Smith DJ, Monto AS, Nguyen-Van-Tam JS, Osterhaus AD.

Vaccine. 2013 Dec 5;31(50):6030-3. doi: 10.1016/j.vaccine.2013.09.063. Epub 2013 Oct 3.

PMID:
24095882
7.

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption.

Allard SD, De Keersmaecker B, de Goede AL, Verschuren EJ, Koetsveld J, Reedijk ML, Wylock C, De Bel AV, Vandeloo J, Pistoor F, Heirman C, Beyer WE, Eilers PH, Corthals J, Padmos I, Thielemans K, Osterhaus AD, Lacor P, van der Ende ME, Aerts JL, van Baalen CA, Gruters RA.

Clin Immunol. 2012 Mar;142(3):252-68. doi: 10.1016/j.clim.2011.10.010. Epub 2011 Nov 16.

PMID:
22177848
8.

Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.

Beyer WE, Nauta JJ, Palache AM, Giezeman KM, Osterhaus AD.

Vaccine. 2011 Aug 5;29(34):5785-92. doi: 10.1016/j.vaccine.2011.05.040. Epub 2011 May 30. Review.

PMID:
21624411
9.

Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host.

de Wit E, Munster VJ, van Riel D, Beyer WE, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA.

J Virol. 2010 Feb;84(3):1597-606. doi: 10.1128/JVI.01783-09. Epub 2009 Nov 25.

10.

Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002.

Voordouw AC, Beyer WE, Smith DJ, Sturkenboom MC, Stricker BH.

Vaccine. 2009 Dec 11;28(2):392-7. doi: 10.1016/j.vaccine.2009.09.138. Epub 2009 Oct 28.

PMID:
19878750
11.

On the relationship between mean antibody level, seroprotection and clinical protection from influenza.

Nauta JJ, Beyer WE, Osterhaus AD.

Biologicals. 2009 Aug;37(4):216-21. doi: 10.1016/j.biologicals.2009.02.002. Epub 2009 Mar 5.

PMID:
19268607
12.

Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests.

Munster VJ, Baas C, Lexmond P, Bestebroer TM, Guldemeester J, Beyer WE, de Wit E, Schutten M, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

J Clin Microbiol. 2009 Mar;47(3):666-73. doi: 10.1128/JCM.01625-08. Epub 2008 Dec 24.

13.

Mortality benefits of influenza vaccination in elderly people.

Thijs C, Beyer WE, Govaert PM, Sprenger MJ, Dinant GJ, Knottnerus A.

Lancet Infect Dis. 2008 Aug;8(8):460-1; author reply 463-5. doi: 10.1016/S1473-3099(08)70161-0. No abstract available.

PMID:
18652989
14.

Influenza vaccine dosages.

Palache AM, Beyer WE, Osterhaus AD.

Vaccine. 2008 May 2;26(19):2305-6. doi: 10.1016/j.vaccine.2008.03.007. Epub 2008 Mar 27. No abstract available.

PMID:
18407384
15.

Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1).

Keawcharoen J, van Riel D, van Amerongen G, Bestebroer T, Beyer WE, van Lavieren R, Osterhaus AD, Fouchier RA, Kuiken T.

Emerg Infect Dis. 2008 Apr;14(4):600-7. doi: 10.3201/eid1404.071016.

17.

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.

Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, Rimmelzwaan GF, Kroon FP.

Ann Rheum Dis. 2008 May;67(5):713-6. Epub 2007 Oct 26.

PMID:
17965123
18.

The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses.

Munster VJ, de Wit E, van Riel D, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Kuiken T, Fouchier RA.

J Infect Dis. 2007 Jul 15;196(2):258-65. Epub 2007 Jun 4.

PMID:
17570113
19.

Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds.

Munster VJ, Baas C, Lexmond P, Waldenström J, Wallensten A, Fransson T, Rimmelzwaan GF, Beyer WE, Schutten M, Olsen B, Osterhaus AD, Fouchier RA.

PLoS Pathog. 2007 May 11;3(5):e61.

20.
21.

Highly pathogenic avian influenza (H7N7): vaccination of zoo birds and transmission to non-poultry species.

Philippa JD, Munster VJ, Bolhuis Hv, Bestebroer TM, Schaftenaar W, Beyer WE, Fouchier RA, Kuiken T, Osterhaus AD.

Vaccine. 2005 Dec 30;23(50):5743-50. Epub 2005 Sep 19.

PMID:
16298028
22.

Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.

de Wit E, Munster VJ, Spronken MI, Bestebroer TM, Baas C, Beyer WE, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

J Virol. 2005 Oct;79(19):12401-7.

23.

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?

Beyer WE, Palache AM, Lüchters G, Nauta J, Osterhaus AD.

Virus Res. 2004 Jul;103(1-2):125-32.

PMID:
15163500
24.

Haemagglutination-inhibiting antibody to influenza virus.

de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD.

Dev Biol (Basel). 2003;115:63-73. Review.

PMID:
15088777
25.

[Neuraminidase inhibitors oseltamivir and zanamivir: new means of defence against influenza].

de Jong JC, Beyer WE, Rimmelzwaan GF, Fouchier RA, Osterhaus AD.

Ned Tijdschr Geneeskd. 2004 Jan 10;148(2):73-9. Review. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2004 Feb 14;148(7):348.

PMID:
14753128
26.

Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.

van den Hoogen BG, van Doornum GJ, Fockens JC, Cornelissen JJ, Beyer WE, de Groot R, Osterhaus AD, Fouchier RA.

J Infect Dis. 2003 Nov 15;188(10):1571-7. Epub 2003 Oct 27.

PMID:
14624384
27.
28.

A randomized, double blind study in young healthy adults comparing cell mediated and humoral immune responses induced by influenza ISCOM vaccines and conventional vaccines.

Rimmelzwaan GF, Nieuwkoop N, Brandenburg A, Sutter G, Beyer WE, Maher D, Bates J, Osterhaus AD.

Vaccine. 2000 Dec 8;19(9-10):1180-7.

PMID:
11137255
29.

Routine influenza vaccination for healthy children--old concept, new technologies.

Beyer WE.

Arch Dis Child. 2000 Dec;83(6):461-2. No abstract available.

31.

Efficacy of influenza vaccination in adult liver transplant recipients.

Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ, Beyer WE, Tilanus HW, Kemmeren MH, Metselaar HJ, de Man RA, Osterhaus AD.

J Med Virol. 2000 May;61(1):85-93.

PMID:
10745238
32.

Protection against influenza after annually repeated vaccination: a meta-analysis of serologic and field studies.

Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD.

Arch Intern Med. 1999 Jan 25;159(2):182-8.

PMID:
9927102
33.

The plea against annual influenza vaccination? 'The Hoskins' Paradox' revisited.

Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD.

Vaccine. 1998 Dec;16(20):1929-32.

PMID:
9796045
34.

Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly.

de Bruijn IA, Remarque EJ, Beyer WE, le Cessie S, Masurel N, Ligthart GJ.

Vaccine. 1997 Aug-Sep;15(12-13):1323-9.

PMID:
9302738
35.

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.

Beyer WE, Palache AM, Sprenger MJ, Hendriksen E, Tukker JJ, Darioli R, van der Water GL, Masurel N, Osterhaus AD.

Vaccine. 1996 Oct;14(14):1331-9.

PMID:
9004442
36.

Adjuvancy and reactogenicity of N-acetylglucosaminyl-N-acetylmuramyl-dipeptide (GMDP) orally administered just prior to trivalent influenza subunit vaccine. A double-blind placebo-controlled study in nursing home residents.

Palache AM, Beyer WE, Hendriksen E, Gerez L, Aston R, Ledger PW, de Regt V, Kerstens R, Rothbarth PH, Osterhaus AD.

Vaccine. 1996 Oct;14(14):1327-30.

PMID:
9004441
37.

Gender differences in local and systemic reactions to inactivated influenza vaccine, established by a meta-analysis of fourteen independent studies.

Beyer WE, Palache AM, Kerstens R, Masurel N.

Eur J Clin Microbiol Infect Dis. 1996 Jan;15(1):65-70.

PMID:
8641306
38.

[Influenza epidemic in a nursing home caused by a virus not included in the vaccine].

Beyer WE, Bakker G, van Beek R, Masurel N.

Ned Tijdschr Geneeskd. 1993 Sep 25;137(39):1973-7. Dutch.

PMID:
8413706
39.

Impact of influenza on mortality in relation to age and underlying disease, 1967-1989.

Sprenger MJ, Mulder PG, Beyer WE, Van Strik R, Masurel N.

Int J Epidemiol. 1993 Apr;22(2):334-40.

PMID:
8505193
40.

Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers.

Palache AM, Beyer WE, Sprenger MJ, Masurel N, de Jonge S, Vardy A, Charpentier B, Noury J, van Beek WC, Borst RJ, et al.

Vaccine. 1993;11(1):3-9.

PMID:
8427034
41.

Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.

Palache AM, Beyer WE, Lüchters G, Völker R, Sprenger MJ, Masurel N.

Vaccine. 1993;11(9):892-908. Review.

PMID:
8212834
42.

Influenza: relation of mortality to morbidity parameters--Netherlands, 1970-1989.

Sprenger MJ, Mulder PG, Beyer WE, Masurel N.

Int J Epidemiol. 1991 Dec;20(4):1118-24.

PMID:
1800412
43.

Influenza-related excess mortality in The Netherlands 1989/90.

Sprenger MJ, Diepersloot RJ, Beyer WE, Masurel N.

Lancet. 1990 Aug 11;336(8711):382. No abstract available.

PMID:
1975365
44.

Effect of immunomodulator thymopentin on impaired seroresponse to influenza vaccine in patients on haemodialysis.

Beyer WE, Noordzij TC, Kramer P, Diderich PP, Op den Hoek CT, Janssen J, Masurel N, Weimar W.

Nephron. 1990;54(4):296-301.

PMID:
2183079
45.
46.

Antibody induction by influenza vaccines in the elderly: a review of the literature.

Beyer WE, Palache AM, Baljet M, Masurel N.

Vaccine. 1989 Oct;7(5):385-94. Review.

PMID:
2683459
47.

[Influenza season 1988-89; vaccine composition for the 1989-90 season].

Masurel N, Diepersloot RJ, Beyer WE.

Ned Tijdschr Geneeskd. 1989 Mar 25;133(12):635-6. Dutch. No abstract available.

PMID:
2716884
48.

Intact humoral immune response in patients on continuous ambulatory peritoneal dialysis.

Versluis DJ, Beyer WE, Masurel N, Diderich PP, Kramer P, Weimar W.

Nephron. 1988;49(1):16-9.

PMID:
3380215
49.

[Influenza in the winter of 1986-87; modification of influenza vaccine for the 1987-88 season].

Masurel N, Beyer WE.

Ned Tijdschr Geneeskd. 1987 Nov 21;131(47):2132-3. Dutch. No abstract available.

PMID:
3683651
50.

Humoral immune response and delayed type hypersensitivity to influenza vaccine in patients with diabetes mellitus.

Diepersloot RJ, Bouter KP, Beyer WE, Hoekstra JB, Masurel N.

Diabetologia. 1987 Jun;30(6):397-401.

PMID:
3678660

Supplemental Content

Loading ...
Support Center